Transgender individuals often face unique challenges in aligning their physical bodies with their true gender identity. Among the various methods employed, gender-affirming hormone therapy (GAHT) stands as a vital means for ...
May 30, 2024
0
0
The American Cancer Society estimates there are nearly 300,000 new cases of prostate cancer every year in the U.S., and approximately one in eight men will be diagnosed with prostate cancer in their lifetime. Prostate cancer ...
May 22, 2024
0
5
The desire for a sculpted physique is driving some amateur gymgoers to experiment with synthetic steroids—specifically, testosterone supplements. This trend is largely being driven by social media, with thousands of posts ...
May 18, 2024
0
1
It has long been thought that testosterone shortens men's lives. Studies in neutered animals and Korean eunuchs seem to confirm this. However, a new study, published in the Annals of Internal Medicine, draws these findings ...
May 15, 2024
0
0
A systematic review and meta-analysis found that a low baseline (endogenous) serum testosterone concentration in men is associated with increased risk for all-cause mortality, and a very low baseline testosterone with increased ...
May 14, 2024
0
23
Musculoskeletal pain is a prevalent menopause symptom, which helps explain why women typically experience more pain than men, especially around the age of 50 years. Beyond pain, muscle function and mass are also affected ...
May 1, 2024
0
0
In terms of men's health issues, prostate cancer features high on the agenda. It's the second most diagnosed cancer in men globally—closely followed by lung cancer. And it's the most common cancer in men in the UK.
Apr 24, 2024
0
3
Now we're seeing a rise in stories about "Ozempic babies," where women who use drugs like Ozempic (semaglutide) report unexpected pregnancies.
Apr 18, 2024
0
0
Online stores sprang up during the COVID-19 pandemic's telehealth boom touting testosterone as a cure-all for men's age-related illnesses—despite FDA rules issued years ago restricting such "low testosterone" advertising.
Mar 28, 2024
0
0
A study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction ...
Mar 13, 2024
0
13
